Reuters: U.S. has bought 195 million doses of H1N1 vaccine

The U.S. government has bought 195 million doses of H1N1 swine flu vaccine for a possible autumn vaccination campaign, a U.S. federal official said Thursday.

The U.S. Health and Human Services Department has also contracted for 120 million doses of adjuvant, a compound to stretch the number of doses of vaccine needed, the department's Dr. Robin Robinson told a meeting of Food and Drug Administration advisers.

Five companies are making H1N1 vaccine for the U.S. market -- AstraZeneca's MedImmune unit, Australia's CSL Ltd, GlaxoSmithKline Plc, Novartis AG and Sanofi-Aventis SA.

Earlier, an FDA official said vaccine makers were only getting about 30 percent as much vaccine from eggs as they usually get with seasonal influenza vaccine.

Reuters: U.S. has bought 195 million doses of H1N1 vaccine

CBC News - Health officials: Tamiflu-resistant strain is rare

Health officials say a recent Quebec case of drug-resistant swine flu shouldn't prompt Canada to change its approach to Tamiflu, as the strain remains rare worldwide.

A 60-year-old Quebec man is one of five people around the world found to have a strain of H1N1 flu resistant to the antiviral drug Tamiflu (oseltamivir). The other cases occurred in Japan, Denmark and Hong Kong.

The Quebecer was given a low preventive dose of Tamiflu as a precaution because he had a pulmonary condition and doctors thought he might have been exposed to swine flu.

CBC News - Health officials: Tamiflu-resistant strain is rare

Sky News UK: Swine Flu Latest: 100,000 New Swine Flu Cases Reported In Past Week

One hundred thousand new cases of swine flu have been recorded in the last seven days.

The figure for England is double the total of the previous week.

Some 840 people are described as being 'seriously ill' in hospital with the illness - and 63 people are being treated in intensive care.

The death toll in the UK stands at 31, but that is likely to climb when the Department of Health releases its weekly update online later.

Sky News UK: Swine Flu Latest: 100,000 New Swine Flu Cases Reported In Past Week

ComputerWorld Hong Kong: Swine flu raises telework questions

The possibility of a widespread swine flu outbreak is prompting companies to think about business continuity and how options such as telework or telecommuting may become a necessity.
A recent whitepaper by Nortel Networks on business continuity and teleworking posed the following questions to enterprises:

1. Can your business operate at 60% of its employee capacity?

2. Due to quarantine mandates, can you maintain business operations when you cannot permit your employees to work from their office?

3. How do you continue to conduct business when health officials and your organization have banned your business travel into affected geographical areas?

4. During times of crisis, do you have the capability and capacity to seamlessly communicate status and share information with all stakeholders

Companies that have solid telework plans in place are in good shape, says Chuck Wilsker, president and CEO of the Telework Coalition in the US.
Those that aren’t prepared to have employees work offsite may find operations at a standstill if the swine flu threat were to escalate to the point of widespread absenteeism or building closures.

ComputerWorld Hong Kong: Swine flu raises telework questions

Cartoons

More A/H1N1 cartoons here

CBS News Video: H1N1 Pregnancy Risks

On CBS News dr. Jennifer Ashton spoke with Harry Smith about the heightened flu danger for pregnant women.

CBS News Video: H1N1 Pregnancy Risks

CNN.com: U.S. trials for H1N1 vaccine announced

In a race to beat the flu season, medical institutes across the United States will begin human trials for a new H1N1 flu vaccine starting in early August, the University of Maryland announced Wednesday.
Concern about the H1N1 virus grew after it spread quickly around the globe earlier this year.

Concern about the H1N1 virus grew after it spread quickly around the globe earlier this year.

In the hope of getting the vaccine to those who will need it most by October, the clinical trials will enroll as many as 1,000 adults and children at 10 centers nationwide, said officials at the Center for Vaccine Development at the University of Maryland School of Medicine, which will lead the effort. The trials will measure the safety and effectiveness of the vaccine.

The research is a first step toward U.S. health officials' goal of developing a safe and effective vaccine against H1N1, also known as swine flu, which has been declared a global pandemic by the World Health Organization

The time frame for developing a vaccine is a tight one.

'It's going to be close,' said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. 'I believe it can be [ready by October] if things run smoothly. We hope they will, but you never can tell when you're dealing with biological phenomena like making vaccines and administering them.'

The announcement of the U.S. trials followed the announcement earlier this week, by an Australian company, CSL Ltd., of the first human trials of a swine flu vaccine.

CNN.com: U.S. trials for H1N1 vaccine announced